Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Azoulay

Showing results (1-10 of 238) with videos related to

Pageof 24
Sort By:
Diabetes Care|May 23, 2015
Incretin-based drugs and adverse pancreatic events: almost a decade later and uncertainty remainsLaurent Azoulay
The Oncologist|June 28, 2022
Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and PerspectiveLaurent Azoulay
The Lancet. Oncology|April 1, 2021
Elucidating the association between antihypertensive drugs and cancer: a need for real-world studiesLaurent Azoulay
Gut|December 3, 2021
Response by Abrahami et al to letter regarding article 'Proton pump inhibitors and risk of colorectal cancer'Devin Abrahami, Laurent Azoulay
Diabetes Care|February 23, 2013
Response to comment on: Smiechowski et al. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care 2013;36:124-129Samy Suissa, Laurent Azoulay
Diabetes Care|May 25, 2013
Response to Yang and Chan. Metformin and the risk of cancer: time-related biases in observational studies. Diabetes care 2012;35:2665-2673Samy Suissa, Laurent Azoulay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Statins in the prevention of prostate cancer recurrence: are certain biases exaggerating the results?Laurent Azoulay, Samy Suissa
Circulation|February 6, 2013
Letter by Azoulay and Suissa regarding article, "statins and the risk of cancer after heart transplantation"Laurent Azoulay, Samy Suissa
Diabetes Care|November 23, 2012
Metformin and the risk of cancer: time-related biases in observational studiesSamy Suissa, Laurent Azoulay
Diabetes Care|June 26, 2014
Metformin and cancer: mounting evidence against an associationSamy Suissa, Laurent Azoulay
Pageof 24

Showing results (1-10 of 238) with videos related to

Sort By:
Pageof 24
Diabetes Care|May 23, 2015
Incretin-based drugs and adverse pancreatic events: almost a decade later and uncertainty remainsLaurent Azoulay
The Oncologist|June 28, 2022
Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and PerspectiveLaurent Azoulay
The Lancet. Oncology|April 1, 2021
Elucidating the association between antihypertensive drugs and cancer: a need for real-world studiesLaurent Azoulay
Gut|December 3, 2021
Response by Abrahami et al to letter regarding article 'Proton pump inhibitors and risk of colorectal cancer'Devin Abrahami, Laurent Azoulay
Diabetes Care|February 23, 2013
Response to comment on: Smiechowski et al. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care 2013;36:124-129Samy Suissa, Laurent Azoulay
Diabetes Care|May 25, 2013
Response to Yang and Chan. Metformin and the risk of cancer: time-related biases in observational studies. Diabetes care 2012;35:2665-2673Samy Suissa, Laurent Azoulay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Statins in the prevention of prostate cancer recurrence: are certain biases exaggerating the results?Laurent Azoulay, Samy Suissa
Circulation|February 6, 2013
Letter by Azoulay and Suissa regarding article, "statins and the risk of cancer after heart transplantation"Laurent Azoulay, Samy Suissa
Diabetes Care|November 23, 2012
Metformin and the risk of cancer: time-related biases in observational studiesSamy Suissa, Laurent Azoulay
Diabetes Care|June 26, 2014
Metformin and cancer: mounting evidence against an associationSamy Suissa, Laurent Azoulay
Pageof 24